Last 12 months
Inside the activity.
8 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 8 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 28, 2024 Filed Feb 29, 2024 21:29 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
Exercise / conversionCommon Stock | 7,087 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007621 · form4.xml · nonDerivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 126,712 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:28 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 35,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007618 · form4.xml · derivative · entry 5 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,580 Underlying: Common Stock · 35,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:28 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 27,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007618 · form4.xml · derivative · entry 4 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,917 Underlying: Common Stock · 27,916 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:28 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 31,265 | $2.62 | $81,914.30 |
DisclosureSEC source: 0001127602-24-007618 · form4.xml · nonDerivative · entry 3 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,626 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:28 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 35,790 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007618 · form4.xml · nonDerivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,891 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:28 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 27,916 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007618 · form4.xml · nonDerivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 33,457 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · derivative · entry 7 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 66,913 Underlying: Common Stock · 33,457 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 26,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · derivative · entry 6 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,097 Underlying: Common Stock · 26,096 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionRestricted Stock Units · Derivative | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · derivative · entry 5 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Tax withholdingCommon Stock | 25,604 | $2.62 | $67,082.48 |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · nonDerivative · entry 4 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 177,497 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 33,457 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · nonDerivative · entry 3 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,101 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 26,096 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · nonDerivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,644 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:27 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
Exercise / conversionCommon Stock | 8,750 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007614 · form4.xml · nonDerivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 143,548 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 120,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · derivative · entry 7 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,767 Underlying: Common Stock · 120,383 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 91,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · derivative · entry 6 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,363 Underlying: Common Stock · 91,364 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 33,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · derivative · entry 5 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,333 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. F3 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F3 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 61,371 | $2.62 | $160,792.02 |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · nonDerivative · entry 4 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,098,068 F2 · kind: Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 120,383 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · nonDerivative · entry 3 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,159,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 91,364 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · nonDerivative · entry 2 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,039,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 28, 2024 Filed Feb 29, 2024 21:26 UTC |
COATS LONNELDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 33,333 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-24-007612 · form4.xml · nonDerivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 947,692 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:19 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantStock Option (Right to Buy) · Derivative | 59,660 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004472 · form4.xml · derivative · entry 2 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:19 UTC |
Alexander KristenVP, Finance and Accounting
|
GrantRestricted Stock Units · Derivative | 59,660 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004472 · form4.xml · derivative · entry 1 Alexander Kristen · CIK 0001878867 · VP, Finance and Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,660 Underlying: Common Stock · 59,660 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:18 UTC |
WADE JEFFREY LPresident and CFO
|
GrantStock Option (Right to Buy) · Derivative | 314,320 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004470 · form4.xml · derivative · entry 2 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,320 Underlying: Common Stock · 314,320 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:18 UTC |
WADE JEFFREY LPresident and CFO
|
GrantRestricted Stock Units · Derivative | 314,320 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004470 · form4.xml · derivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 314,320 Underlying: Common Stock · 314,320 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:17 UTC |
McDermott WendyVP, Human Resources
|
GrantStock Option (Right to Buy) · Derivative | 156,950 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004468 · form4.xml · derivative · entry 2 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,950 Underlying: Common Stock · 156,950 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:17 UTC |
McDermott WendyVP, Human Resources
|
GrantRestricted Stock Units · Derivative | 156,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004468 · form4.xml · derivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,950 Underlying: Common Stock · 156,950 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:16 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantStock Option (Right to Buy) · Derivative | 204,730 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004466 · form4.xml · derivative · entry 2 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,730 Underlying: Common Stock · 204,730 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:16 UTC |
MAIN ALAN JEVP, Innov & Chem Sciences
|
GrantRestricted Stock Units · Derivative | 204,730 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004466 · form4.xml · derivative · entry 1 MAIN ALAN J · CIK 0001227372 · EVP, Innov & Chem Sciences 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,730 Underlying: Common Stock · 204,730 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:15 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantStock Option (Right to Buy) · Derivative | 203,810 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004464 · form4.xml · derivative · entry 2 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,810 Underlying: Common Stock · 203,810 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:15 UTC |
Kassler-Taub Kenneth B.SVP, Regulatory & QA
|
GrantRestricted Stock Units · Derivative | 203,810 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004464 · form4.xml · derivative · entry 1 Kassler-Taub Kenneth B. · CIK 0001885219 · SVP, Regulatory & QA 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 203,810 Underlying: Common Stock · 203,810 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:14 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 222,680 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004462 · form4.xml · derivative · entry 2 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,680 Underlying: Common Stock · 222,680 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:14 UTC |
Granowitz Craig BSVP, Chief Medical Officer
|
GrantRestricted Stock Units · Derivative | 222,680 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004462 · form4.xml · derivative · entry 1 Granowitz Craig B · CIK 0001876655 · SVP, Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,680 Underlying: Common Stock · 222,680 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:14 UTC |
Garner ThomasSVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 227,130 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004460 · form4.xml · derivative · entry 2 Garner Thomas · CIK 0001996325 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,130 Underlying: Common Stock · 227,130 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:14 UTC |
Garner ThomasSVP, Chief Commercial Officer
|
GrantRestricted Stock Units · Derivative | 227,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004460 · form4.xml · derivative · entry 1 Garner Thomas · CIK 0001996325 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 227,130 Underlying: Common Stock · 227,130 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:12 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantStock Option (Right to Buy) · Derivative | 208,160 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004457 · form4.xml · derivative · entry 2 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,160 Underlying: Common Stock · 208,160 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:12 UTC |
Crum Brian TSVP, General Counsel & Secr.
|
GrantRestricted Stock Units · Derivative | 208,160 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004457 · form4.xml · derivative · entry 1 Crum Brian T · CIK 0001792747 · SVP, General Counsel & Secr. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 208,160 Underlying: Common Stock · 208,160 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:12 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 770,420 | $0.00 Strike: $2.15 | $0.00 |
DisclosureSEC source: 0001127602-24-004455 · form4.xml · derivative · entry 2 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770,420 Underlying: Common Stock · 770,420 shares Expires 2034-02-08 F3 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter. Read SEC document |
| February 08, 2024 Filed Feb 12, 2024 21:12 UTC |
COATS LONNELDirector · Chief Executive Officer
|
GrantRestricted Stock Units · Derivative | 770,420 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-004455 · form4.xml · derivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 770,420 Underlying: Common Stock · 770,420 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. F2 · derivative.exercise_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. F2 · derivative.expiration_date: Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. Read SEC document |
| November 16, 2023 Filed Nov 17, 2023 21:55 UTC |
COATS LONNELDirector · Chief Executive Officer
|
PurchaseCommon Stock | 90,000 | $1.05 | $94,797.00 |
DisclosureSEC source: 0001127602-23-027850 · form4.xml · nonDerivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 914,359 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.05 to $1.06 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Coats hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 21:12 UTC |
Amouyal PhilippeDirector
|
PurchaseCommon Stock | 200,000 | $1.01 | $201,520.00 |
DisclosureSEC source: 0001127602-23-027360 · form4.xml · nonDerivative · entry 1 Amouyal Philippe · CIK 0001376854 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 240,332 F1 · price: This transaction was executed in multiple trades at prices ranging from $0.9858 to $1.0400 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Amouyal hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected. Read SEC document |
| November 10, 2023 Filed Nov 13, 2023 22:31 UTC |
COATS LONNELDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $1.01 | $10,100.00 |
DisclosureSEC source: 0001127602-23-027279 · form4.xml · nonDerivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 824,359 Read SEC document |
| October 12, 2023 Filed Oct 12, 2023 20:01 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 148,820 | $1.03 | $153,805.47 |
DisclosureSEC source: 0001127602-23-025798 · form4.xml · nonDerivative · entry 4 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,340,847 F3 · price: This transaction was executed in multiple trades at prices ranging from $1.02 to $1.07 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected. Read SEC document |
| October 11, 2023 Filed Oct 12, 2023 20:01 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 342,874 | $1.08 | $370,783.94 |
DisclosureSEC source: 0001127602-23-025798 · form4.xml · nonDerivative · entry 3 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,192,027 F2 · price: This transaction was executed in multiple trades at prices ranging from $1.06 to $1.12 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| October 10, 2023 Filed Oct 12, 2023 20:01 UTC |
DEBBANE RAYMONDDirector
|
PurchaseCommon Stock | 508,306 | $1.14 | $579,367.18 |
DisclosureSEC source: 0001127602-23-025798 · form4.xml · nonDerivative · entry 2 DEBBANE RAYMOND · CIK 0001053890 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 849,153 F1 · price: This transaction was executed in multiple trades at prices ranging from $1.09 to $1.19 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Debbane hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected. Read SEC document |
| October 09, 2023 Filed Oct 11, 2023 20:02 UTC |
Garner ThomasSVP, Chief Commercial Officer
|
GrantStock Option (Right to Buy) · Derivative | 248,923 | $0.00 Strike: $1.08 | $0.00 |
DisclosureSEC source: 0001127602-23-025765 · form4.xml · derivative · entry 1 Garner Thomas · CIK 0001996325 · SVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,923 Underlying: Common Stock · 248,923 shares Expires 2033-10-09 F1 · derivative.exercise_date: Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant (10/9/2024) and vests 1/48th per month for each month of service thereafter. Read SEC document |
| September 14, 2023 Filed Sep 14, 2023 21:05 UTC |
WADE JEFFREY LPresident and CFO
|
PurchaseCommon Stock | 10,000 | $1.38 | $13,800.00 |
DisclosureSEC source: 0001127602-23-024201 · form4.xml · nonDerivative · entry 1 WADE JEFFREY L · CIK 0001225767 · President and CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,341 Read SEC document |
| August 04, 2023 Filed Aug 7, 2023 20:13 UTC |
McDermott WendyVP, Human Resources
|
PurchaseCommon Stock | 6,000 | $1.84 | $11,040.00 |
DisclosureSEC source: 0001127602-23-022118 · form4.xml · nonDerivative · entry 1 McDermott Wendy · CIK 0001902760 · VP, Human Resources 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,478 Read SEC document |
| July 27, 2023 Filed Jul 31, 2023 12:14 UTC |
Sullivan Diane E.Director
|
GrantStock Option (Right to Buy) · Derivative | 96,515 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001127602-23-021546 · form4.xml · derivative · entry 1 Sullivan Diane E. · CIK 0001968736 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,515 Underlying: Common Stock · 96,515 shares Expires 2033-07-27 F1 · derivative.exercise_date: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date. Read SEC document |
| June 29, 2023 Filed Jun 29, 2023 20:13 UTC |
COATS LONNELDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $2.16 | $21,600.00 |
DisclosureSEC source: 0001127602-23-019560 · form4.xml · nonDerivative · entry 1 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 814,359 Read SEC document |
| June 26, 2023 Filed Jun 26, 2023 20:04 UTC |
COATS LONNELDirector · Chief Executive Officer
|
PurchaseCommon Stock | 10,000 | $2.18 | $21,792.00 |
DisclosureSEC source: 0001127602-23-019405 · form4.xml · nonDerivative · entry 2 COATS LONNEL · CIK 0001612528 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 804,359 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.